1. Home
  2. KRNY vs LAB Comparison

KRNY vs LAB Comparison

Compare KRNY & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kearny Financial Corp

KRNY

Kearny Financial Corp

HOLD

Current Price

$7.92

Market Cap

504.9M

Sector

Finance

ML Signal

HOLD

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$0.98

Market Cap

354.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRNY
LAB
Founded
1884
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
504.9M
354.1M
IPO Year
2014
2008

Fundamental Metrics

Financial Performance
Metric
KRNY
LAB
Price
$7.92
$0.98
Analyst Decision
Buy
Hold
Analyst Count
2
1
Target Price
$8.00
$1.35
AVG Volume (30 Days)
286.1K
2.4M
Earning Date
04-23-2026
05-05-2026
Dividend Yield
5.51%
N/A
EPS Growth
130.22
61.54
EPS
0.30
N/A
Revenue
$2,580,000.00
$101,937,000.00
Revenue This Year
$3.89
N/A
Revenue Next Year
$17.52
$2.63
P/E Ratio
$26.60
N/A
Revenue Growth
36.00
N/A
52 Week Low
$5.76
$0.87
52 Week High
$8.50
$1.72

Technical Indicators

Market Signals
Indicator
KRNY
LAB
Relative Strength Index (RSI) 59.02 52.37
Support Level $7.77 $0.92
Resistance Level $7.95 $1.01
Average True Range (ATR) 0.16 0.05
MACD 0.06 0.01
Stochastic Oscillator 70.05 88.90

Price Performance

Historical Comparison
KRNY
LAB

About KRNY Kearny Financial Corp

Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Share on Social Networks: